BLUEPRINT MEDICINES CORP shareholders Q2 2023

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 221 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.

BLUEPRINT MEDICINES CORP shareholders Q2 2023
NameSharesValueWeighting ↓
PEREGRINE CAPITAL MANAGEMENT LLC 143,589$9,074,8250.25%
Linden Thomas Advisory Services, LLC 17,212$1,087,8080.24%
Virtus Fund Advisers, LLC 518$32,7380.23%
Virtus ETF Advisers LLC 5,848$369,5940.22%
Woodline Partners LP 291,362$18,414,0780.22%
PDT Partners, LLC 23,194$1,465,8610.20%
Polar Capital Holdings Plc 500,000$31,600,0000.16%
Corton Capital Inc. 4,731$298,9990.14%
PLATINUM INVESTMENT MANAGEMENT LTD 56,171$3,550,0070.12%
Spouting Rock Asset Management, LLC 5,188$327,8820.12%
Neo Ivy Capital Management 3,516$2220.12%
OAK RIDGE INVESTMENTS LLC 14,273$902,0540.11%
MACQUARIE GROUP LTD 1,518,086$95,943,0000.11%
T. Rowe Price Investment Management, Inc. 2,451,035$154,9060.11%
Alkeon Capital Management 943,928$59,656,2490.10%
PANAGORA ASSET MANAGEMENT INC 269,311$17,020,4550.10%
Mraz, Amerine & Associates, Inc. 6,571$415,2870.10%
UBS OCONNOR LLC 47,784$3,019,9490.10%
PROFUND ADVISORS LLC 26,438$1,670,8820.09%
Virtus Investment Advisers, Inc. 1,947$123,0500.08%
External links

This page lists BLUEPRINT MEDICINES CORP's shareholders in Q2 2023. To view BLUEPRINT MEDICINES CORP's shareholder history, click here.